Transactional

Clients ranging from startups and individual entrepreneurs to mature public and private companies, multinational corporations and financial institutions rely on our experienced counsel to turn challenges into business opportunities. 


WilmerHale's Transactional Department includes skilled business counselors and former industry professionals prepared to handle even the most complex transactions and issues, as well as former senior staff members from US government agencies who provide a wealth of regulatory insight. This seasoned team advises clients from a wide array of technology, life sciences and regulated industries, including biotechnology, medical devices, communications, digital media, financial services, energy and cleantech, aviation, education, real estate, retail and the nonprofit sector.

To provide every client with the highest levels of knowledge and experience across a multitude of matters, our Transactional Department attorneys regularly collaborate with the firm's intellectual property, regulatory, securities and litigation authorities. Leading legal publications—including Chambers, The American Lawyer, Law360, The Legal 500 and JUVE—regularly rank our practitioners as the most sophisticated and skilled in the business.

Contacts

Sort By
Singer, Steven D.

Steven D. Singer

Chair, Transactional Department

+1 212 295 6307 (t)

steven.singer@wilmerhale.com

Caporizzo_William_lo

A. William Caporizzo

Vice Chair, Transactional Department

+1 617 526 6411 (t)

william.caporizzo@wilmerhale.com

Publications & News

View

September 30, 2016

China’s Emerging Social Credit System and the Role of the Courts

Persons (both individuals and companies) who are determined in a judicial administrative law proceeding to be socially uncreditworthy will be subject to prohibitions and other restrictions on their commercial, residential and family activities.

September 29, 2016

WilmerHale Advises Altiostar Networks in $60M Venture Capital Financing

The WilmerHale team was led by Partner Mark Borden and included Senior Associate Caroline Dotolo and Associate Alyce Chen.

September 22, 2016

WilmerHale Advises Agios Pharmaceuticals in $173M Public Offering and Full Exercise of Option to Purchase Additional Shares

The WilmerHale team was led by Partner Steven Singer and included Special Counsel Cynthia Mazareas, Senior Associate Mhairi Immermann and Associate Brett Bromann.

September 22, 2016

WilmerHale Reps Eleven Biotherapeutics in Acquisition of Viventia Bio

The acquisition creates a NASDAQ-listed company focused on the development of novel therapies based upon antibody fragments genetically fused to cytotoxic proteins, or targeted protein therapeutics, as new treatments in areas of oncology with significant unmet need.

September 19, 2016

The Legal 500 UK Recognizes Wilmer Cutler Pickering Hale and Dorr LLP as a Top-Tier Firm

In the 2016 edition of The Legal 500 UK, WilmerHale is named a top-tier firm for dispute resolution - international arbitration and crime, fraud and licensing - fraud: white-collar crime, and is recommended in four other practice areas. The guide also names four partners to its "Leading lawyers" list, and recognizes a total of nine of the firm's London-based lawyers.

September 19, 2016

WilmerHale Advises Avocarrot in $20M Acquisition by Glispa Global Group

Native mobile advertising startup Avocarrot announced that it has been acquired by Glispa Global Group, a mobile ad tech pioneer, for $20 million.

September 14, 2016

LMG Life Sciences Recognizes WilmerHale in Multiple Categories on 2016 Award Shortlist

In its annual recognition of the top law firms, lawyers and in-house counsel in the life sciences industry, LMG Life Sciences named WilmerHale to its 2016 award shortlist. 

September 13, 2016

WilmerHale Advises Thermo Fisher Scientific in €1.6B Eurobond Public Offering

Thermo Fisher Scientific Inc. announced the completion of its public offering of €1 billion aggregate principal amount of 0.750% Senior Notes due 2024 and €600 million aggregate principal amount of 1.375% Senior Notes due 2028 at the issue prices of 99.122% of the principal amount and 99.748% of the principal amount, respectively.

September 7, 2016

Anti-Monopoly Disputes Are Not Arbitrable According to Chinese Court

On August 29, the Jiangsu Provincial Higher People's Court ruled that an arbitration clause did not apply to an anti-monopoly dispute in a 10 million yuan ($1.5 million) case brought by a distributor against a manufacturer.

August 29, 2016

Participate in the 2016 CompStudy Survey of Venture-Backed Life Sciences and Technology Companies

WilmerHale invites you to participate in the 2016 CompStudy survey of equity and salary compensation for executives at venture-backed life sciences and technology companies.